CIK 0001652130 · Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364785571
- Phone
- 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,899
- in 3 filings, $395K under 10b5-1 plans
Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Option exercise · Stock Option (right to buy) | −66,000 | 39,117 | ||
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Option exercise · Stock Option (right to buy) | −33,000 | 72,000 | ||
| 2021-02-01 | Rivera Jose E EVP, General Counsel | Option exercise · Stock Option (right to buy) | −10,000 | 61,000 | ||
| 2021-01-20 | Cohen Fred E Director | Option exercise | +20,000 | $13.78 | $276K | 30,000 |
| 2021-01-20 | Cohen Fred E Director | Option exercise · Stock Option (right to buy) | −20,000 | 18,000 | ||
| 2021-01-05 | LEONARD JOHN M President and CEO | Sale | −6,239 | $55.86 | $349K | 475,488 |
| 2021-01-05 | SCHIERMEIER ANDREW EVP, Chief Operating Officer | Sale | −1,377 | $55.86 | $77K | 16,656 |
| 2021-01-05 | Rivera Jose E EVP, General Counsel | Sale | −2,078 | $55.86 | $116K | 51,990 |
| 2020-12-31 | LEONARD JOHN M President and CEO | Option exercise | +14,375 | 481,727 | ||
| 2020-12-31 | LEONARD JOHN M President and CEO | Grant or award · Stock Option (right to buy) | +28,750 | 28,750 | ||
| 2020-12-31 | LEONARD JOHN M President and CEO | Grant or award · Restricted Stock Unit (performance-based) | +14,375 | 14,375 | ||
| 2020-12-31 | LEONARD JOHN M President and CEO | Option exercise · Restricted Stock Unit (performance-based) | −14,375 | 0 | ||
| 2020-12-31 | SCHIERMEIER ANDREW EVP, Chief Operating Officer | Option exercise | +4,792 | 18,033 | ||
| 2020-12-31 | SCHIERMEIER ANDREW EVP, Chief Operating Officer | Grant or award · Stock Option (right to buy) | +9,583 | 9,583 | ||
| 2020-12-31 | SCHIERMEIER ANDREW EVP, Chief Operating Officer | Grant or award · Restricted Stock Unit (performance-based) | +4,792 | 4,792 | ||
| 2020-12-31 | SCHIERMEIER ANDREW EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit (performance-based) | −4,792 | 0 | ||
| 2020-12-31 | Rivera Jose E EVP, General Counsel | Option exercise | +4,792 | 54,068 | ||
| 2020-12-31 | Rivera Jose E EVP, General Counsel | Grant or award · Stock Option (right to buy) | +9,583 | 9,583 | ||
| 2020-12-31 | Rivera Jose E EVP, General Counsel | Grant or award · Restricted Stock Unit (performance-based) | +4,792 | 4,792 | ||
| 2020-12-31 | Rivera Jose E EVP, General Counsel | Option exercise · Restricted Stock Unit (performance-based) | −4,792 | 0 |
Page 28 of 40 · 783 trades